LAPS-IFN-beta

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameLAPS-IFN-beta
Drug Alias Namelong-acting interferon beta conjugate (Hanmi)HM-11460AHM-11460B
ClassificationBiologics
Mechanisms of ActionInterferon alpha/beta receptor agonistsImmunomodulators
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A